Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Vitamin D: Preeclampsia - Nutraceuticals World
Research

Vitamin D: Preeclampsia

Nutraceutical: Vitamin D
 
Indication: Preeclampsia
 
Source: Am J Obstet Gynecol, August 9, 2010: Epub ahead of print.
 
Research: Vitamin D deficiency has been linked to adverse pregnancy outcomes. The purpose of this investigation was to assess total 25-hydroxyvitamin D (25-OH-D) levels at diagnosis of early-onset severe preeclampsia (EOSPE). Researchers enrolled 50 subjects with EOSPE (<34 weeks’ gestation with severe preeclampsia) in this case-control investigation in a 1:2 ratio with 100 gestation-matched, contemporaneous control subjects. Demographic and outcome information was collected for each subject. Plasma total 25-OH-D levels were determined by radioimmunoassay and reported in nanograms per milliliter. Results were analyzed by Mann-Whitney U and multivariable regression.
 
Results: Subjects with EOSPE were noted to have decreased total 25-OH-D levels relative to healthy control subjects. This difference in total 25-OH-D remained significant after control for potential confounders. Total 25-OH-D is decreased at diagnosis of EOSPE, but researchers say further study is needed to understand the impact of vitamin D deficiency on pregnancy outcomes.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters